Your browser doesn't support javascript.
loading
Multidimensional analysis of endometriosis clinical trials based on the ClinicalTrials.gov database / 中国临床药理学与治疗学
Article in Zh | WPRIM | ID: wpr-1024626
Responsible library: WPRO
ABSTRACT
AIM:To perform a multidimensional analysis of the clinical study characteristics of endo-metriosis based on the ClinicalTrials.gov,providing comprehensive and objective information for re-searchers,clinicians,and clinical pharmacists.METHODS:A thorough investigation was conduct-ed on clinical trials related to endometriosis,regis-tered on the ClinicalTrials.gov from its inception to October 20,2023.Relevant trial data were extract-ed and statistically analyzed using bibliometrics and comparative research methods.RESULTS:A to-tal of 667 endometriosis clinical studies were regis-tered globally,showing an annual increase.The United States(127 trials),France(70 trials),and Ita-ly(57 trials)had the highest number of registered trials.Interventional studies were predominant(416 trials,62.4%),followed by observational stud-ies(251 trials,37.6%).Within interventional stud-ies,drug therapy was the primary intervention(223 trials,53.6%).Despite endometriosis being a female condition,male subjects were also consid-ered,with 6 trials specifically requiring male partici-pants and 37 trials not restricting gender.Compa-nies/corporations were the main funding sources,while public and governmental organizations pro-vided relatively less funding.CONCLUSION:Clinical trial research on endometriosis is in a phase of growth,with drug therapy being the main treat-ment approach.However,there is a relative lack of investment and attention from public funds and governmental organizations.
Key words
Full text: 1 Index: WPRIM Language: Zh Journal: Chinese Journal of Clinical Pharmacology and Therapeutics Year: 2024 Type: Article
Full text: 1 Index: WPRIM Language: Zh Journal: Chinese Journal of Clinical Pharmacology and Therapeutics Year: 2024 Type: Article